Navigation Links
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
Date:1/4/2008

ck,

non-fatal stroke or cardiovascular death (p<0.001).

-- 52 percent reduction compared with clopidogrel in stent thrombosis

(p<0.0001).

-- 30 percent relative risk reduction compared to clopidogrel in a subset

of patients with diabetes (p<0.001) on the composite endpoint of non-

fatal heart attack, non-fatal stroke, or cardiovascular death.

Risk reductions in the primary composite endpoint with prasugrel compared to clopidogrel were seen as early as three days and continued to diverge for 15 months (the duration of the trial.)

Though the incidence of non-coronary artery bypass grafting(non-CABG) bleeding in TRITON was low in both the prasugrel and clopidogrel treatment groups, prasugrel-treated patients experienced significantly higher non-CABG major bleeding (2.2% vs. 1.7%, respectively) and higher rates of life- threatening bleeding (1.3% vs. 0.8%, respectively). Death from cardiovascular causes (2% vs. 2.2%, respectively) and all-cause death (2.8% vs. 2.9%, respectively) was comparable among prasugrel-treated patients and clopidogrel- treated patients. The overall results demonstrated that for every 1,000 patients treated with prasugrel as compared with clopidogrel, there were 22 fewer patients with heart attacks and five more non-CABG-related TIMI major bleeds.

"Given the overall results from TRITON, this submission is particularly meaningful considering that cardiovascular disease is the leading cause of death in the United States and worldwide, killing 16.7 million people each year," said John Alexander, M.D., M.P.H., global head of research and development, Daiichi Sankyo Company, Limited.

Acute heart attacks and unstable angina, called acute coronary syndrome, affect more than 840,000 Americans each year and 800,000 people in Europe.(i,ii) Utilizing current medical interventions and treatments, 300,000 people continue to experience recurrent heart attacks and 450,000 people die fro
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
2. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
3. Lilly Declares Fourth-Quarter Dividend
4. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
5. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
6. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
7. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
11. Cephalon Submits Supplemental New Drug Application for FENTORA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... can go downhill fast when a patient has sepsis, ... in a patient,s blood -- often too fast for ... human spleen and developed by a team at Harvard,s ... the way doctors treat sepsis. , "Even with ... intensive care units at least 30 percent of the ...
(Date:9/15/2014)... 2014  iVinci Health LLC, the company behind the ... system, branded as VisitPay®, has successfully closed $5 million ... of a new extension to VisitPay® – an online ... convenient way for patients to manage their medical bills ... and their families. The new round of ...
(Date:9/15/2014)... 15 septembre 2014 La deuxième édition ... (semaine internationale sur la sensibilisation au plasma) ... conjointe de la Plasma Protein Therapeutics Association ... , l,IPAW vise à : , ... la collecte du plasma-aphérèse , Reconnaître la ...
(Date:9/14/2014)... regulate protein functions in a wide variety of ways, ... a protein can take on another form and perform ... that fold wrongly can cause serious diseases such as ... also have a tendency to "infect" other molecules of ... fibrils or plaques. These amyloids can damage cells and ...
Breaking Biology Technology:Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Measuring modified protein structures 2Measuring modified protein structures 3
... N.J., Jan. 7 Par Pharmaceutical Companies, Inc. (NYSE: ... Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at ... The audio-only live webcast will be accessible through the J.P. ... the Par website at www.parpharm.com . A replay ...
... Technology Index Shows Stronger Performance in Turbulent EconomyOAKBROOK TERRACE, ... trade association representing all segments of the high-tech industry, ... Index (Nasdaq: ILTI ) outperformed the Dow ... Index(R) (COMP) since its inception in 2008.On May 19, ...
... and Efficient Cold Chain VisibilityBEVERLY, Mass., Jan. 7 ... in cold-chain visibility solutions, has launched the TempTale(R)4USB ... latest model of the industry-leading TempTale4 product line ... without proprietary software or readers. Sensitech is a ...
Cached Biology Technology:NASDAQ OMX AeA Illinois Tech Index Outperforms Market 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 3Introducing Sensitech's TempTale(R)4USB Temperature Monitor 2Introducing Sensitech's TempTale(R)4USB Temperature Monitor 3
(Date:9/15/2014)... The creation of the Vuoksi River and the subsequent ... approximately 6,000 years ago revealed thousands of square kilometres ... research project organised by University of Helsinki researchers has ... has played in the interaction between nature and humans. ... the area underwent significant changes and gave rise to ...
(Date:9/15/2014)... Schizophrenia is generally considered to be a disorder ... both genetic and environmental, with other neurodevelopmental disorders such ... for brain development is determined by the combined effects ... range of environmental factors. , However, longitudinal brain imaging ... in order to map the disturbances in brain structures ...
(Date:9/15/2014)... , , , , , , , ... , , , , , , ... shows that schizophrenia isn,t a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be ... , , , , , ... , , , , ...
Breaking Biology News(10 mins):The creation of the Vuoksi River preceded a significant cultural shift 2Brain Development in Schizophrenia Strays from the Normal Path 2Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5
... to tackle the human impact on biodiversity require ... working with common goals and frameworks. This emerged ... Science Foundation (ESF), which moved towards establishing an ... biodiversity analysis on the back of existing initiatives. ...
... dating back to the journals of Henry David Thoreau, scientists ... Walden Pond have borne the effects of climate change in ... by global warming have included beloved species like lilies, orchids, ... in the Proceedings of the National Academy of Sciences ...
... release is available in French . ... $100,000 grant from the Gates Foundation to help establish ... "People are always asking why the pharmaceutical ... the poor, like parasitic infections," said Dr. Timothy Geary, ...
Cached Biology News:European biodiversity and ecosystem scientists merge and gear up for long-term research 2Effects of climate change vary greatly across plant families 2Boost from McGill, Gates Foundation helps Africans control pharma research 2
Newborn Bovine Serum Heat-Inactivated...
... MagicMark XP Western Protein Standards are ... protein molecular weight estimation directly on ... an IgG binding site, allowing direct ... used to detect your target protein ...
... is the most effective ... PCR products. TOPO TA ... TOPO vectors are supplied ... topoisomerase I. This enables ...
... Conjugated peptides or recombinant proteins are ... produce antibodies in 2 rabbits. pre-immune and ... test until the titer reaches 1:4,000 Western ... Protein G purification Antibodies are eluted using ...
Biology Products: